123 related articles for article (PubMed ID: 26883151)
1. Renal Tumors in 26-Week Tg.Rash2 Mice Carcinogenicity Studies.
Paranjpe MG; Belich JL; McKeon ME; Elbekai RH; Mann PC; Hard GC; Seely JC
Toxicol Pathol; 2016 Jul; 44(5):633-5. PubMed ID: 26883151
[TBL] [Abstract][Full Text] [Related]
2. Historical control data of spontaneous tumors in transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice.
Paranjpe MG; Elbekaei RH; Shah SA; Hickman M; Wenk ML; Zahalka EA
Int J Toxicol; 2013; 32(1):48-57. PubMed ID: 23324159
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of spontaneous amphophilic-vacuolar renal tubule tumors in Sprague-Dawley rats from subchronic toxicity studies.
Crabbs TA; Frame SR; Laast VA; Patrick DJ; Thomas J; Zimmerman B; Hardisty JF
Toxicol Pathol; 2013 Aug; 41(6):866-71. PubMed ID: 23262636
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Spontaneous Tumors in Tg.rasH2 Mice in 26-week Carcinogenicity Studies Conducted at a Single Test Facility during 2004 to 2012 and 2013 to 2018.
Paranjpe MG; Belich JL; Mann PC; McKeon ME; Elbekai RH; Brown CM; Patrick DJ
Toxicol Pathol; 2019 Jan; 47(1):18-25. PubMed ID: 30407148
[TBL] [Abstract][Full Text] [Related]
5. High Background Incidence of Spontaneous Subcapsular Adrenal Gland Hyperplasia of Tg.rasH2 Mice Used in 26-week Carcinogenicity Studies.
Boyle MH; Paranjpe MG; Creasy DM
Toxicol Pathol; 2018 Jun; 46(4):444-448. PubMed ID: 29695215
[TBL] [Abstract][Full Text] [Related]
6. Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies.
Paranjpe MG; Belich J; Vidmar TJ; Elbekai RH; McKeon M; Brown C
Int J Toxicol; 2017; 36(4):287-292. PubMed ID: 28553733
[TBL] [Abstract][Full Text] [Related]
7. Twenty-six-week oral carcinogenicity study of 3-monochloropropane-1,2-diol in CB6F1-rasH2 transgenic mice.
Lee BS; Park SJ; Kim YB; Han JS; Jeong EJ; Son HY; Moon KS
Arch Toxicol; 2017 Jan; 91(1):453-464. PubMed ID: 27017489
[TBL] [Abstract][Full Text] [Related]
8. Incidence of spontaneous non-neoplastic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic mice.
Paranjpe MG; Shah SA; Denton MD; Elbekai RH
Toxicol Pathol; 2013; 41(8):1137-45. PubMed ID: 23427275
[TBL] [Abstract][Full Text] [Related]
9. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
Mitsumori K; Koizumi H; Nomura T; Yamamoto S
Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
[TBL] [Abstract][Full Text] [Related]
10. The rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals.
Nambiar PR; Morton D
Toxicol Pathol; 2013; 41(8):1058-67. PubMed ID: 23423820
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
[TBL] [Abstract][Full Text] [Related]
12. The Tg rasH2 mouse in cancer hazard identification.
Morton D; Alden CL; Roth AJ; Usui T
Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
14. Trend analysis of body weight parameters, mortality, and incidence of spontaneous tumors in Tg.rasH2 mice.
Paranjpe MG; Denton MD; Vidmar T; Elbekai RH
Int J Toxicol; 2014; 33(6):475-81. PubMed ID: 25260361
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Carcinogenic Potential of Enarodustat (JTZ-951), a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor, in 26-Week Tg.rasH2 Mouse Study and 2-Year Sprague-Dawley Rat Study.
Kemmochi Y; Toyoda K; Ishida T; Yasui Y; Shoda T
Int J Toxicol; 2023 Dec; 42(6):489-503. PubMed ID: 37480334
[TBL] [Abstract][Full Text] [Related]
16. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.
Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T
Toxicol Pathol; 2003; 31(2):191-9. PubMed ID: 12696579
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
